Colgate-Palmolive Co.
Colgate-Palmolive Co. Q3 FY2026 earnings call
October 30, 2026 · fiscal period ended 2026-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-10-30
Management highlights
- Global Growth & Execution: Delivered solid top-line and bottom-line growth despite global volatility. Base business EPS exceeded expectations due to operating leverage from productivity programs.
- U.S. Turnaround Strategy: Focused on scaling premium innovation while reinforcing core brands. Strengthening marketing models with a sharper focus on digital, social, and emerging agentic commerce channels.
- AI & Technology Integration: Scaling AI capabilities globally via 'PromoAI' for promotional optimization and proprietary platforms for faster new product ideation. Using data personalization to enhance advertising ROI.
- Cost Management & Productivity: Driving gross margin expansion through 'Funding the Growth' and 'SGPP' (Sales, Growth, and Productivity Program) initiatives, which offset significant material cost inflation. Pricing actions contributed ~80 basis points of favorable impact.
- Hills Pet Nutrition Success: Strong performance driven by strategic focus on growing segments like cat food and wet food. Launching 'Fresh' single-protein diets in a disciplined, methodical rollout to ensure quality and long-term sustainability.
- Emerging Markets Momentum: India and Brazil are key drivers with strong volume and premiumization. China is navigating a challenging brick-and-mortar environment but showing strength in online/social commerce platforms like Douyin.
Segment performance
The company reported broad-based organic sales growth across all four categories and four of its five divisions. Emerging markets led performance with mid-single-digit growth, driven by strong results in India (double digits), Brazil (double digits), and China (mid-single digits for Colgate brand). Europe delivered record market shares through science-based premium innovation and omni-channel strategies. The Hills Pet Nutrition business performed exceptionally well, with therapeutic dog food up mid-single digits and therapeutic cat food up double digits. In the U.S., toothpaste market share showed early signs of improvement, though the overall category remains sluggish. Latin America grew organically by 6%, supported by double-digit growth in Brazil and resilient performance in Andina and Central America, despite headwinds in Mexico.
Guidance
- Gross Margin: Raised full-year gross margin guidance to be up year-on-year (previously guided for roughly flat), driven by confidence in productivity offsets and pricing levers despite elevated commodity costs.
- Cost Environment: Expects raw material and freight/logistics cost pressures to remain elevated through Q4 and into 2027. Tariffs are expected to peak in Q4. FX movements are volatile and acting as a headwind.
- 2027 Outlook: No specific financial guidance provided for 2027; will be shared in Q1 2027. Management anticipates continued need for pricing actions to offset stubborn cost inflation globally.
Risks
- Commodity Volatility: Persistent inflation in oil-based commodities (resins, petrochemicals) and pulp/paper prices continues to pressure margins.
- Freight & Logistics Costs: Escalating fuel costs are driving higher freight expenses, which hit the P&L faster than commodity costs flowing through inventory.
- Foreign Exchange Uncertainty: Currency fluctuations, particularly against the Brazilian Real and other emerging market currencies, create volatility.
- Regional Consumer Weakness: Specific challenges in Mexico due to retailer issues and consumer backdrop uncertainty; China's brick-and-mortar sector remains soft.
- Tariff Impact: Potential ongoing impacts from tariffs, although refunds were insignificant in Q3.
Q&A highlights
Q: Peter Galbo asked about 2027 outlook and cost environment specifics.
A: Noel Wallace stated that 2027 guidance will be provided in Q1 2027. He emphasized that the current business model helps offset stubborn global cost environments. Tariffs are expected to peak in Q4, and while FX is moving unfavorably, the company has levers to control execution. They are focused on delivering against controllable factors rather than predicting external macro variables.
Q: Dara Mohsenian asked about drivers of gross margin upside and advertising ROI.
A: Noel Wallace explained that pricing (contributing ~200 bps in Q3) was critical to getting ahead of costing. Premium innovation (e.g., Hills therapeutic, Optic White) and strong volume leverage at manufacturing facilities also drove margin. Stan Sutula added that productivity initiatives ('Funding the Growth') offset over 290 bps of material inflation. Advertising spend has increased significantly, but management feels very good about the ROI, especially with AI-driven optimization.
Q: Peter Grom asked for details on Hills' strong performance and future growth.
A: Noel Wallace noted Hills grew 6.5% ex-private label, above expectations. Growth was driven by strategic focus on high-growth segments like cat food and wet food, where they are under-indexed. Therapeutic prescription cat food grew double digits. Gross margin for Hills was up 170 bps, allowing for accelerated advertising spend. They are launching 'Fresh' diets carefully to build long-term sustainable growth.
Q: Steve Powers asked about Latin America momentum, specifically Brazil and Mexico.
A: Noel Wallace highlighted Latin America grew 6% organically, with Brazil up double digits due to premium oral care and shower gel execution. Mexico faced retailer challenges and a tough consumer backdrop, causing slowness, but management expects these to subside in Q4. Brazil faces currency risk post-election, but fundamentals remain strong. Oral care shares are up across the region.
Q: Filippo Falorni asked about U.S. toothpaste improvements and category environment.
A: Noel Wallace described the U.S. turnaround as a work in process requiring time. Key steps include repowering marketing around premium innovation, stepping up omni-demand generation, and restructuring go-to-market teams to better connect with consumers via data. Categories are sluggish but may inflect positively with strong innovation cycles in 2027. Pricing will be necessary globally to offset costs, executed differently by brand.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.97 | $0.93 | +4.6% | $0.91 |
| Revenue | $5.37B | $5.34B | +0.6% | $5.13B |
Transcript
October 30, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.